BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23454573)

  • 1. Dual asymmetric centrifugation as an alternative preparation method for parenteral fat emulsions in preformulation development.
    Tenambergen F; Maruiama CH; Mäder K
    Int J Pharm; 2013 Apr; 447(1-2):31-7. PubMed ID: 23454573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections.
    Ishii F; Nagasaka Y
    Colloids Surf B Biointerfaces; 2004 Aug; 37(1-2):43-7. PubMed ID: 15450307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oil-in-water emulsions manufactured by microfluidization and homogenization.
    Pinnamaneni S; Das NG; Das SK
    Pharmazie; 2003 Aug; 58(8):554-8. PubMed ID: 12967032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by design approach for the preparation of fat-soluble vitamins lipid injectable emulsion.
    Deng Y; Zhong G; Wang Y; Wang N; Yu Q; Yu X
    Int J Pharm; 2019 Nov; 571():118717. PubMed ID: 31610279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain specific delivery of pegylated indinavir submicron lipid emulsions.
    Kandadi P; Syed MA; Goparaboina S; Veerabrahma K
    Eur J Pharm Sci; 2011 Mar; 42(4):423-32. PubMed ID: 21292000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on preparation of intravenous submicron emulsions of Oleum Cinnamomi oil of Miao nationality herbal].
    Li J; Liu YB
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2374-7. PubMed ID: 18257262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery.
    Müller RH; Harden D; Keck CM
    Drug Dev Ind Pharm; 2012 Apr; 38(4):420-30. PubMed ID: 22088169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature.
    Kadam AN; Najlah M; Wan KW; Ahmed W; Crean SJ; Phoenix DA; Taylor KM; Elhissi AM
    Pharm Dev Technol; 2014 Dec; 19(8):999-1004. PubMed ID: 24093888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle size reduction of emulsions by formulation design. I: Effect of polyhydroxy alcohols.
    Chanana GD; Sheth BB
    J Parenter Sci Technol; 1993; 47(3):130-4. PubMed ID: 8360805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs.
    Wang JJ; Sung KC; Hu OY; Yeh CH; Fang JY
    J Control Release; 2006 Oct; 115(2):140-9. PubMed ID: 16959357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies of commercial fat emulsions used in parenteral nutrition.
    Li J; Caldwell KD
    J Pharm Sci; 1994 Nov; 83(11):1586-92. PubMed ID: 7891280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical stability assessments of lipid emulsions of varying oil composition.
    Driscoll DF; Giampietro K; Wichelhaus DP; Peterss H; Nehne J; Niemann W; Bistrian BR
    Clin Nutr; 2001 Apr; 20(2):151-7. PubMed ID: 11327743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization, pharmacokinetics, tissue distribution and antitumor activity of honokiol submicron lipid emulsions in tumor-burdened mice.
    Zheng J; Tang Y; Sun M; Zhao Y; Li Q; Zhou J; Wang Y
    Pharmazie; 2013 Jan; 68(1):41-6. PubMed ID: 23444779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of the stability of lipid emulsions in mixtures for peripheral parenteral nutrition].
    Selva Otaolaurruchi J; Ruiz López I; Marco Garbayo JL; Burgos San José A; Provencio Arranz RM
    Nutr Hosp; 1989; 4(3):154-7. PubMed ID: 2485366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stability study of paediatric extemporaneous parenteral nutrition with lipids].
    Tuan F; Montalto M; Pell MB; Bianchi M; Pendica S; Traverso ML
    Nutr Hosp; 2011; 26(3):522-7. PubMed ID: 21892570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of fat emulsions in ternary mixing during total parenteral feeding on biological and galenic parameters].
    Sarocchi C; Choux C; Thillard JG; Seguier JC; Brossard D
    Agressologie; 1989 Apr; 30(4):207-14. PubMed ID: 2506772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, characterization and stability evaluation of ciprofloxacin-loaded parenteral nutrition nanoemulsions.
    Said Suliman A; Tom R; Palmer K; Tolaymat I; Younes HM; Arafat B; Elhissi AMA; Najlah M
    Pharm Dev Technol; 2020 Jun; 25(5):579-587. PubMed ID: 31967908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term stability of lipid emulsions with parenteral nutrition solutions.
    Tannuri U; Sesso A; Coelho MC; Maksoud JG
    Nutrition; 1992; 8(2):98-100. PubMed ID: 1591460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of the hemolytic activity of microemulsions in human erythrocytes.
    Aparicio RM; José García-Celma M; Pilar Vinardell M; Mitjans M
    J Pharm Biomed Anal; 2005 Oct; 39(5):1063-7. PubMed ID: 16054795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.